Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Compass Pathways

Clinical trials sponsored by Compass Pathways, explained in plain language.

Compass Pathways CMPS NASDAQ

Biotech company developing psilocybin-based therapies for mental health conditions.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Magic mushroom compound takes on tough depression in major trial

Symptom relief Completed

This phase 3 trial tests whether a single dose of COMP360 psilocybin, given under supportive conditions, can safely reduce depression symptoms in 255 adults with treatment-resistant depression. Participants are randomly assigned to receive either the drug or a placebo, and their …

Phase: PHASE3 • Sponsor: COMPASS Pathways • Aim: Symptom relief

Last updated Aug 12, 2026 00:00 UTC